We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of TARO yet.

TARO Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2025, worth a combined $0 — down 100% from $3.27K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TARO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was MassMutual Private Wealth & Trust, exiting entirely with an estimated $3.27K sold.

  • 0 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2025, down from 1 in Q3 2025.
  • Funds reported $0 of Taro Pharmaceutical Industries Ltd. stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2025 was MassMutual Private Wealth & Trust, an estimated $3.27K sold.

Based on aggregated 13F filings for Q4 2025.